Novartis Investigative Site

Berlin, New Jersey 08009

0 studies enrolling now · 6 studies all time

What they study most

Depressive Disorder, Treatment-Resistant, Diabetes Mellitus, Type 2, Non-alcoholic Steatohepatitis (NASH), Osteopenia, Osteoporosis, Persistent Asthma

Studies at this site

• Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density — Completed
• Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression — Completed
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes — Completed
• Efficacy, Safety, and Pharmacokinetics of QAW039 — Completed
• Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol — Completed